Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Diagnos Inc. (V:ADK)

Business Focus: IT Services & Consulting (NEC)

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for ADK within the last 6 months
See all filings within the past 6 months

Company News

Nov 25, 2022 11:36 ET
DIAGNOS Announces Closing of Private Placement
DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the closing of a...
Read full article
Oct 27, 2022 11:29 ET
DIAGNOS Enters the Retinal Diagnostics Market With its New 3D Image Analysis Technology
DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is proud to announce it is...
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Nov 15, 202259,16658,719
Oct 31, 2022447-60,045
Oct 15, 202260,49255,405
See Short Report

Business Summary

Sector:  Technology Industry:  IT Services & Consulting

DIAGNOS Inc. is a Canada-based company that is engaged in the early detection of health problems based on its FLAIRE artificial intelligence (AI) platform. The Company operates through healthcare services. FLAIRE allows for quick modifying and developing of applications, such as CARA (Computer Assisted Retina Analysis). The Company markets CARA, a software platform that assists health specialists in the detection of diabetic retinopathy. CARA is a tool for the real-time screening of large volumes of patients. Its geographical areas include Canada, the United States, Saudi Arabia, Mexico and Costa Rica. The Company's subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.

See business summary



Search (past week) for $ADK.CA ADK.V